Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
2024 Standout
Non-small-cell lung cancer
2024 Standout
Works of Bharani Dharan being referenced
1194MO Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results
2021
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Bharani Dharan | 118 | 141 | 151 | 10 | 316 | |
| Dianne Spillman | 125 | 170 | 136 | 8 | 365 | |
| Emily Wearne | 100 | 157 | 151 | 6 | 314 | |
| Wilcox Ws | 42 | 150 | 135 | 10 | 363 | |
| Wendy R. Tate | 65 | 56 | 254 | 9 | 335 | |
| Jiang Liu | 94 | 113 | 145 | 11 | 260 | |
| Jessica C. Walrath | 51 | 85 | 130 | 7 | 325 | |
| Amandine Quivy | 119 | 204 | 82 | 9 | 338 | |
| Sabine Turri | 111 | 153 | 149 | 12 | 322 | |
| Giuliana Pavone | 55 | 100 | 123 | 17 | 257 | |
| Luis Paz-Ares Rodríguez | 157 | 179 | 84 | 15 | 302 |
All Works
Login with ORCID to disown or claim papers
Loading papers...